Data / Form D filings / Aurin Biotech Inc.
Aurin Biotech Inc.: Form D filing
Aurin Biotech Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2018. The latest, on June 25, 2018, reports $795,029 sold of a $795,029 offering to 2 investors.
Find out what Aurin Biotech Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4727 WEST 2ND AVENUE, Vancouver, British Columbia, Canada, V6T 1
- Phone
- (604) 224-6403
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1744372
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | New notice | $795,029 | $795,029 | $0 | 2 | May 2, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas Bell | Director | |
| Patrick McGeer | Executive Officer, Director | |
| Andy von Flowtow | Director | |
| Hagen Kennecke | Director | |
| Edith McGeer | Director |
Every Form D from the week of Jun 25, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aurin Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.